CD1d-restricted T-cell subsets and dendritic cell function in autoimmunity

Immunology and Cell Biology

Volumn 82, Issue 3, 2004, Pages 307-314

  Bollyky, Paul L ^a   Wilson, S Brian ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Autoimmunity; Dendritic cell; Diabetes; Immunoregulation; iNKT cell

Indexed keywords

CD1 ANTIGEN;

AUTOIMMUNITY; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL MIGRATION; DENDRITIC CELL; DIABETES MELLITUS; HOST RESISTANCE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; NONHUMAN; REVIEW; T LYMPHOCYTE; TUMOR IMMUNITY;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD1; AUTOIMMUNITY; CELL COMMUNICATION; CELL MOVEMENT; DENDRITIC CELLS; HUMANS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTE SUBSETS;

EID: 3042842679     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0818-9641.2004.01253.x     Document Type: Review

References (116)

1. Calabi F, Jarvis JM, Martin L, Milstein C. Two classes of CD1 genes. European J. Immunol. 1989; 19: 285-92.
2. Dascher CC, Brenner MB. Evolutionary constraints on CD1 structure: insights from comparative genomic analysis. Trends Immunol. 2003; 24: 412-8.
3. Vincent MS. Understanding the function of CD1-restricted cells. Nature Immunol. 2003; 4: 517-23.
4. Dellabona P, Casorati G, Friedli B et al. In vivo persistence of expanded clones specific for bacterial antigens within the human T cell receptor a/b CD4-8- subset. J. Exp. Med. 1993; 177: 1763-71.
5. Porcelli S, Yockey CE, Brenner MB, Balk SP. Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- a/b T cells demonstrates preferential use of several Vb genes and an invariant TCR a chain. J. Exp. Med. 1993; 178: 1-16.
6. Bendelac A. CD1: Presenting unusual antigens to unusual T lymphocytes. Science 1995; 269: 185-6.
7. Porcelli SA, Modlin RL. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 1999; 17: 297-329.
8. Wilson SB, Delovitch TL. Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity. Nat. Rev. Immunol. 2003; 3: 211-22.
9. Kronenberg M, Gapin L. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2002; 2: 557-68.
10. Gumperz JE, Miyake S, Yamamura T, Brenner MB. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 2002; 195: 625-36.
11. Gumperz JE, Roy C, Makowska A et al. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 2000; 12: 211-21.
12. Spada FM, Koezuka Y, Porcelli SA. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J. Exp. Med. 1998; 188: 1529-34.
13. Kawano T, Cui J, Koezuka Y et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycoceramides. Science 1997; 278: 1626-9.
14. Naidenko OV, Maher JK, Ernst WA, Sakai T, Modllin RL, Kronenberg M. Binding and Antigen Presentation of Ceramide-containing glycolipids by Soluble Mouse and Human CD1d Molecules. J. Exp. Med. 1999; 190: 1069-79.
15. Gadola SD, Dulphy N, Salio M, Cerundolo V. Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4(+) and CD8alphabeta(+) T lymphocytes. J. Immunol. 2002; 168: 5514-20.
16. Behar SM, Podrebarac TA, Roy CJ, Wang CR, Brenner MB. Diverse TCRs recognize murine CD1. J. Immunol. 1999; 162: 161-7.
17. Cardell S, Tangri S, Chan S, Kronenberg M, Benoist C, Mathis D. CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice. J. Exp. Med. 1995; 182: 993-1004.
18. Skold M, Rytter A, Ivars F, Cardell S. Characterization of subpopulations of T-cell receptor intermediate (TCRint) T cells. Scand. J. Immunol. 1999; 49: 611-9.
19. Thomas SY, Hou R, Boyson JE et al. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J. Immunol. 2003; 171: 2571-80.
20. Tahir SM, Cheng O, Shaulov A et al. Loss of IFN-gamma production by invariant NK T cells in advanced cancer. J. Immunol. 2001; 167: 4046-50.
21. Gansuvd B, Hubbard WJ, Hutchings A et al. Phenotypic and functional characterization of long-term cultured rhesus macaque spleen-derived NKT cells. J. Immunol. 2003; 171: 2904-11.
22. Yang OO, Racke FK, Nguyen PT et al. CD1d on myeloid dendritic cells stimulates cytokine secretion and cytolytic activity of V alpha 24J α Q T cells: a feedback mechanism for immune regulation. J. Immunol. 2000; 165: 3756-62.
23. Kawano T, Nakayama T, Kamada N et al. Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells. Cancer Res. 1999; 59: 5102-5.
24. Kaneko BY, Harada M, Kawano T et al. Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J. Exp. Med. 2000; 191: 105-14.
25. Matsuda JL, Gapin L, Baron JL et al. Mouse V14i NKT cells are resistant to cytokine polarization in vivo. Proc. Natl. Acad. Sci. USA 2003; 100: 8395-400.
26. Hammond KIL, Poulton LD, Palmisano LJ, Silveira PA, Godfrey DI, Baxter AG. alpha/beta-T cell receptor (TCR) +CD4-CD8-(NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med. 1998; 187: 1047-56.
27. Hong SMT, Wilson I, Serizawa L et al. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 2001; 7: 1052-6.
28. Singh AK, Wilson MT, Hong S, Olivares-Villagomez D et al. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J. Exp. Med. 2001; 194: 1801-11,
29. Akbari OP, Stock E, Meyer M et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 2003; 9: 582-8.
30. Terabe M, Matsui S, Noben-Trauth N et al. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nature Immunol 2000; 1: 515-20.
31. Terabe M, Matsui S, Park JM et al. Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence. J. Exp. Med. 2003; 198: 1741-52.
32. Nieuwenhuis EE, Matsumoto T, Exley M et al. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat. Med. 2002; 8: 588-93.
33. Gonzalez-Aseguinolaza G. Galactosylceramide-activated V, 14 natural killer T cells mediate protection against murine malaria. Proc. Natl Acad. Sci. USA 2000; 97: 8461-6.
34. Pied S, Roland J, Louise A et al. Liver CD4-CD8-NK1.1+ TCR alpha beta intermediate cells increase during experimental malaria infection and are able to exhibit inhibitory activity against the parasite liver stage in vitro. J. Immunol. 2000; 164: 1463-9.
35. Chackerian A, Alt J, Perera V, Behar SM. Activation of NKT cells protects mice from tuberculosis. Infect. Immun. 2002; 70: 6302-9.
36. Duthie MSK. S.J. Treatment with alpha-galactosylceramide before Trypanosoma cruzi infection provides protection or induces failure to thrive. J. Immunol. 2002; 168: 5778-85.
37. Exley MA, Bigley NJ, Cheng O et al. CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus. J. Leukoc. Biol. 2001; 69: 713-8.
38. Kitamura H, Iwakabe K, Yahata T et al. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL) - 12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 1999; 189: 1121-8.
39. Smyth MJ, Taniguchi M, Street SE. The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent. J. Immunol. 2000; 165: 2665-70.
40. Brigl M, Bry L, Kent SC, Gumperz JE, Brenner MB. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 2003; 4: 1230-7.
41. Schofield L, McConville MJ, Hansen D et al. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 1999; 283: 225-9.
42. Molano A, Park SH, Chiu YH, Nosseir S, Bendelac A, Tsuji M. Cutting edge: the IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: exploring the role of GPIs in NK T cell activation and antimalarial responses. J. Immunol. 2000; 164: 5005-9.
43. Procopio DO, Almeida IC, Torrecilhas AC et al. Glycosylphos- phatidylinositol-anchored mucin-like glycoproteins from Trypanosoma cruzi bind to CD1d but do not elicit dominant innate or adaptive immune responses via the CD1d/NKT cell pathway. J. Immunol. 2002; 169: 3926-33.
44. Mempel M, Ronet C, Suarez F et al. Natural Killer T Cells Restricted by the Monomorphic MHC Class Ib CD1d1 Molecules Behave Like Inflammatory Cells. J. Immunol. 2002; 168: 365-71.
45. Exley M, Garcia J, Balk SP, Porcelli S. Requirements for CD1d Recognition by Human Invariant Va24+ CD4-CD8- T Cells. J. Exp. Med. 1997; 186: 1-11.
46. Kawakami K, Kinjo Y, Yara S et al. Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans. Infect. Immun. 2001; 69: 213-20.
47. Johnson TR, Hong S, Van Kaer L, Koezuka Y, Graham BS. NK T cells contribute to expansion of CD8+ T cells and amplification of antiviral immune responses to respiratory syncytial virus. J. Virol. 2002; 76: 4294-303.
48. Kumar H, Belperron A, Barthold SW, Bockenstedt LK. Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi. J. Immunol. 2000; 165: 4797-801.
49. Smyth MJ, Crowe NY, Pellicci DG et al. Sequential production of interferon-gamma by NK1.1 (+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide. Blood 2002; 99: 1259-66.
50. Cui J, Shin T, Kawano T et al. Requirement for Val4 NKT cells in IL-12-mediated rejection of tumors. Science 1997; 278: 1623-6.
51. Tomura M, Yu WG, Ahn HJ et al. A Novel Function of Valpha14+CD4+NKT Cells: Stimulation of IL-12 Production by Antigen-Presenting Cells in the Innate Immune System. J. Immunol. 1999; 163: 93-101.
52. Pal E, Tabira T, Kawano T, Taniguchi M, Miyake S, Yamamura T. Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of V alpha 14 NK T cells. J. Immunol. 2001; 166: 662-8.
53. Jahng AW, Maricic I, Pedersen B et al. Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J. Exp. Med. 2001; 194: 1789-99.
54. Wilson SB, Kent SC, Patton KT et al. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 1998; 391: 177-81.
55. Sumida T, Sakamoto A, Murata H et al. Selective reduction of T cells bearing invariant Va24JaQ antigen receptor in patients with systemic sclerosis. J. Exp. Med. 1995; 182: 1163-8.
56. Illes Z, Kondo T, Newcombe J, Oka N, Tabira T, Yamamura T. Differential Expression of NK T Cell Valpha24JalphaQ Invariant TCR Chains in the Lesions of Multiple Sclerosis and Chronic Inflammatory Demyelinating Polyneuropathy. J. Immunol. 2000; 164: 4375-81.
57. van der Vliet HJ, von Blomberg BM, Nishi N et al. Circulating V (alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin. Immunol. 2001; 100: 144-8.
58. Kita H, Naidenko OV, Kronenberg M et al. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology 2002; 123: 1031-43.
59. Nagane Y, Utsugisawa K, Obara D, Tohgi H. NKT-associated markers and perform in hyperplastic thymuses from patients with Myasthenia gravis. Muscle Nerve 2001; 24: 1359-64.
60. Saubermann LJ, Beck P, De Jong YP et al. Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice. Gastroenterology 2000; 119: 119-28.
61. Dellabona P, Padovan E, Casorati G, Brockhaus M, Lanzavecchia A. An invariant Va24-JaQ/Vb11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells. J. Exp. Med. 1994; 180: 1171-6.
62. Wilson SB, Byrne MC. Gene expression in NKT cells: defining a functionally distinct CD1d- restricted T cell subset. Curr. Opin. Immunol. 2001; 13: 555-61.
63. Lee PT, Benlagha K, Teyton L, Bendelac A. Distinct functional lineages of human V (alpha) 24 natural killer T cells. J. Exp. Med. 2002; 195: 637-41.
64. Hou R, Goloubeva O, Neuberg DS, Strominger JL, Wilson SB. Interleukin-12 and IL-2-induced iNKT cell cytokine expression independent of TCR activation. Immunology 2004 (in press).
65. Kang SJ, Cresswell P. Regulation of intracellular trafficking of human CD1d by association with MHC class II molecules. EMBO J. 2002; 21: 1650-60.
66. Kim CH, Johnston B, Butcher EC. Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(+) V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity. Blood 2002; 100: 11-6.
67. Stenstrom M, Skold M, Ericsson A et al. Surface receptors identify mouse NK1.1+ T cell subsets distinguished by function and T cell receptor type. Eur J. Immunol. 2004; 34: 56-65.
68. Banchereau J, Briere F, Caux C et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000; 18: 767-811.
69. Steinman RM, Nussenzweig MC. Inaugural Article: Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance. Proc. Natl Acad. Sci. USA 2002; 99: 351-8.
70. Green EA, Flavell RA. The temporal importance of TNFalpha expression in the development of diabetes. Immunity 2000; 12: 459-69.
71. Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 2000; 191: 423-34.
72. Steinman RM, Turley S, Mellman I, Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells [comment]. J. Exp. Med. 2000; 191: 411-6.
73. Hawiger D, Inaba K, Dorsett Y et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 2001; 194: 769-79.
74. Mathis D, Vence L, Benoist C. beta-Cell death during progression to diabetes. Nature 2001; 414: 792-8.
75. Menges M, Rossner S, Voigtlander C et al. Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 2002; 195: 15-21.
76. Probst HC, Lagnel J, Kollias G, van den Broek M. Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance. Immunity 2003; 18: 713-20.
77. Naumov YN, Bahjat KS, Gausling R et al. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc. Natl Acad. Sci. USA 2001; 98: 13838-433.
78. Fujii S, Shimizu K, Smith C, Bonifaz L, Steinman RM. Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 2003; 198: 267-79.
79. Gillessen S, Naumov YN, Nieuwenhuis EE et al. CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion. Proc. Natl Acad. Sci. USA 2003; 100: 8874-9.
80. Wilson SB, Kent SC, Horton HF et al. Multiple differences in gene expression in regulatory Valpha24JalphaQ T cells from identical twins discordant for type I diabetes. Proc. Natl Acad. Sci. USA 2000; 97: 7411-6.
81. Vincent MS, Leslie DS, Gumperz JE, Xiong X, Grant EP, Brenner MB. CD1-dependent dendritic cell instruction. Nat. Immunol. 2002; 3: 1163-8.
82. Leslie DS, Vincent MS, Spada FM et al. CD1-mediated gamma/ delta T cell maturation of dendritic cells. J. Exp. Med. 2002; 196: 1575-84.
83. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-52.
84. Falcone M, Yeung B, Tucker L, Rodriguez E, Sarvetnick N. A defect in interleukin 12-induced activation and interferon gamma secretion of peripheral natural killer T cells in non-obese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus. J. Exp. Med. 1999; 190: 963-72.
85. Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH. Induction of interleukin 10-producing, nonproliferating CD4 (+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 2000; 192: 1213-22.
86. Wakkach A, Fournier N, Brun V, Breittmayer JP, Cottrez F, Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 2003; 18: 605-17.
87. Oldenhove G, de Heusch M, Urbain-Vansanten G et al. CD4+ CD25+ regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo. J. Exp. Med. 2003; 198: 259-66.
88. Lohr J, Knoechel B, Jiang S, Sharpe AH, Abbas AK. The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens. Nat. Immunol. 2003; 4: 664-9.
89. Yamazaki S, Iyoda T, Tarbell K et al. Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 2003; 198: 235-47.
90. Fujii S, Shimizu K, Kronenberg M, Steinman RM. Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs. Nat. Immunol. 2002; 3: 867-74.
91. Vincent MS, Gumperz JE, Brenner MB. Understanding the function of CD1-restricted T cells. Nat. Immunol. 2003; 4: 517-23.
92. Gombert JM, Herbelin A, Tancrede-Bohin E, Dy M, Carnaud C, Bach JF. Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse. Eur. J. Immunol. 1996; 26: 2989-98.
93. Mieza MA, Itoh T, Cui JQ et al. Selective reduction of Va14+ NK T cells associated with disease development in autoimmune-prone mice. J. Immunol. 1996; 156: 4035-40.
94. Baxter AG, Kinder SJ, Hammond KJL, Scollay R, Godfrey DI. Association between abTCR+CD4-CD8- T-cell defiency and IDDM in NOD/Lt mice. Diabetes 1997; 46: 572-82.
95. Wang B, Geng YB, Wang CR. Cd1-restricted NK T cells protect nonobese diabetic mice from developing diabetes. J. Exp. Med. 2001; 194: 313-20.
96. Matsuda JL, Gapin L, Sidobre S et al. Homeostasis of V alpha 14i NKT cells. Nat. Immunol. 2002; 3: 966-74.
97. Berzins SP, Venanzi ES, Benoist C, Mathis D. T-cell compartments of prediabetic NOD mice. Diabetes 2003; 52: 327-34.
98. Sharif S, Arreaza GA, Zucker P et al. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat. Med. 2001; 7: 1057-62.
99. Lehuen A, Lantz O, Beaudoin L et al. Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 1998; 188: 1831-9.
100. Kukreja AG, Cost J, Marker C et al. Multiple immunoregulatory defects in type-1 diabetes. J. Clin. Invest. 2002; 109: 131-40.
101. Lee PT, Putnam A, Benlagha K, Teyton L, Gottlieb PA, Bendelac A. Testing the NKT cell hypothesis of human IDDM pathogenesis. J. Clin. Invest. 2002; 110: 793-800.
102. Oikawa Y, Shimada A, Yamada S et al. High frequency of valpha24 (+) vbeta11 (+) T-cells observed in type 1 diabetes. Diabetes Care 2002; 25: 1818-23.
103. Poulton LD, Smyth MJ, Hawke CG et al. Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice. Int. Immunol. 2001; 13: 887-96.
104. Laloux V, Beaudoin L, Jeske D, Carnaud C, Lehuen A. NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen. J. Immunol. 2001; 166: 3749-56.
105. Sharif S, Arreaza GA, Zucker P, Delovitch TL. Regulatory natural killer T cells protect against spontaneous and recurrent type 1 diabetes. Ann. NY Acad. Sci. 2002; 958: 77-88.
106. Shi FD, Flodstrom M, Balasa B et al. Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse. Proc. Natl Acad. Sci. USA 2001; 98: 6777-82.
107. Serreze DV, Gaskins HR, Leiter EH. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. J. Immunol. 1993; 150: 2534-43.
108. Takahashi K, Honeyman MC, Harrison LC. Impaired yield, phenotype, and function of monocyte-derived dendritic cells in humans at risk for insulin-dependent diabetes. J. Immunol. 1998; 161: 2629-35.
109. Alleva DG, Pavlovich RP, Grant C, Kaser SB, Beller DI. Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice. Diabetes 2000; 49: 1106-15.
110. Poligone B, Weaver DJ Jr, Sen P, Baldwin AS Jr, Tisch R. Elevated NF-kappaB activation in nonobese diabetic mouse dendritic cells results in enhanced APC function. J. Immunol. 2002; 168: 188-96.
111. Beaudoin L, Laloux V, Novak J, Lucas B, Lehuen A. NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic beta cells. Immunity 2002; 17: 725-36.
112. Golub TR, Slonim DK, Tamayo P et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286: 531-7.
113. Alizadeh AA, Eisen MB, Davis RE et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503-11.
114. Rogge L, Bianchi E, Biffi M et al. Transcript imaging of the development of human T helper cells using oligonucleotide arrays. Nat. Genet. 2000; 25: 96-101.
115. Tamayo P, Slonim D, Mesirov J et al. Interpreting gene expression with self-organizing maps: Methods and application to hematopoeitic differentiation. Proc. Natl Acad. Sci. USA 1999; 96: 2907-12.
116. Seo J, Shneiderman B. Interactively Exploring Hierarchical Clustering Results. IEEE Computer 2002; 35: 80-6.